e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD
Casanova Crio, Celli Bartolome R.
Source:
Eur Respir J 2014; 43: 951-953
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Casanova Crio, Celli Bartolome R.. Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD. Eur Respir J 2014; 43: 951-953
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Microalbuminuria as a cardiovascular biomarker in patients with COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Lipocalin-2: a biomarker potentially associated with predisposition to COPD
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019
Year: 2019
ß
2
-adrenoceptor modulation in COPD and its potential impact on cardiovascular comorbidities
Source: Eur Respir Monogr 2020; 88: 229-237
Year: 2020
Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?
Source: Eur Respir J 2015; 46: 846-849
Year: 2015
Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014
Study of microalbuminuria in COPD patients and its association with cardiac comorbidities
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Pilot: identification of rehospitalization risk factors for patients with COPD
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
Presence of cardiovascular risk markers in OSAS
Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Year: 2007
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Acute exacerbation in COPD and relationship between cardiovascular risk and functional profile
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018
PP302 – The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Source: ERS Lung Science Conference 2021
Year: 2021
Identification of novel diagnostic biomarkers of chronic thromboembolic pulmonary hypertension using MALDI-TOF-MS
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept